Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-12-03
1999-07-20
Morris, Patricia L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483471, 5483481, 5483491, 5483511, 5483531, 5483541, A61K 31415, C07D23364
Patent
active
059256656
ABSTRACT:
Compound of formula (I): in which R is as defined in the description, as well as their isomers and their pharmaceutically acceptable acid additions salts. Medicinal products containing the same are useful as Imidazoline receptors ligand.
REFERENCES:
patent: 4140859 (1979-02-01), Houlihan, II
patent: 4298748 (1991-11-01), Dockner et al.
patent: 4910206 (1990-03-01), Houlihan, I
patent: 5154858 (1992-10-01), Wakita et al.
Wagner et al "Agents for Affecting the Rheological, etc" CA 89: 113808 (1978).
Levesque et al, "4,5-Dihydorimidazoles from, etc" CA 96:122690 (1982).
Keem et al, "Dehydrogenation of 2-aryl-2-, etc" CA 72: 121439 (1970).
A. Schulz et al., "Dual action of clonidine on insulin release: suppression, but stimulation when .alpha..sub.2 -adrenoceptors are blocked", Naunya-Schmiedeberg's Arch Pharmocal (1989) 340: 712-714.
R. E. Klem et al., "Dehydrogenation of 2-Aryl-2-imidazolines with Selenium"Notes XP-002058798, Apr. 1970, p. 403.
Anastassiadou Maria
Baziard-Mouysset Genevieve
Caignard Daniel-Henri
Danoun Saadia
Manechez Dominique
Adir et Compagnie
Hueschen Gordon W.
Morris Patricia L.
LandOfFree
Imidazoline compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazoline compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazoline compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1322246